The Correlation Between Iron Overload and Endocrine Function in Adult Transfusion-Dependent Beta-Thalassemia Patients with Growth Retardation

References

• Wahidayat I, Wahidayat PA. Genetic problems at present and their challenges in the future: as a model of thalassemia. Paediatr Indonesiana. 2006;46(5):189–194. doi:10.14238/pi46.5.2006.189-94
   Google Scholar
• Sofro ASM. Molecular pathology of beta-thalassemia in Indonesia. Southeast Asian J Trop Med Public Health. 1995;26:221–224.
   PubMedGoogle Scholar
• Thalassemia Center Cipto Mangunkusumo Hospital. Data Thalassemia Major Patients in Indonesia in 2015–2016. Jakarta; 2016.
   Google Scholar
• Sanctis VD, Soliman AT, Skordis N. Endocrine disease. In: Cappellini CA, Porter J, editors. Guidelines for the Management of Transfusion-Dependent Thalassemia (TDT). 3rd ed. Cyprus: Thalassemia International Federation; 2014:146–157.
   Google Scholar
• Soliman A, Sanctis VD, Yassin M, Abdelrahman MO. Growth hormone – insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major. Indian J Endocrinol Metab. 2014;18(1):32c–8.
   Google Scholar
• Abdelhadi MA. Endocrinopathies in beta-thalassemia major: prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia. Saudi Med J. 2013;34(1):67–73.
   Web of Science ®Google Scholar
• Perera NJ, Lau NS, Mathew S, Waite C, Ho PJ, Caterson ID. Overview of endocrinopathies associated with b-thalassemia major. Intern Med J. 2010;40(10):689–696. doi:10.1111/j.1445-5994.2010.02254.x
   PubMed Web of Science ®Google Scholar
• Poggi M, Pascucci C, Monti S, et al. Prevalence of adult growth hormone deficiency in β-thalassemia polytransfused Patients and Correlation with transfusional and chelation parameters. J Endocrinol Invest. 2010;33(8):534–538. doi:10.1007/BF03346643
   Web of Science ®Google Scholar
• Sanctis VD, Urso L, Scialpi V. Endocrine complications in β-thalassemia major. In: Maggio A, Hoffbrand AV, editors. Clinical Aspects and Therapy of Hemoglobinopathies. Italy: SEE-Firenze; 2014:293–315.
   Google Scholar
• Olivieri NF, Weatherall DJ. Clinical aspects ofβ-thalassemia and related disorders. In: Steinberg MH, Forget BG, Higgs DR, editors. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. UK: Cambridge University Press; 2009:357–369.
   Google Scholar
• Kuskonmaz BC. Endocrinological problems in adult thalassemia patients. Gazi J Med. 2014;25:173–176.
   Google Scholar
• Tzoulis P. Review of endocrine complications in adult patients with β-thalassemia major. Thalassemia Rep. 2014;4:51–56.
   Google Scholar
• Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body of iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7–15. doi:10.1007/s12185-008-0120-5
   PubMed Web of Science ®Google Scholar
• Crichton R. Iron and Oxidative Stress. Iron Metabolism - from Molecular Mechanisms to Clinical Consequences. 3rd ed. UK: Willey; 2009:346–367.
   Google Scholar
• Barton JC, Edwards CQ, Phatak PD, Britton RS, Bacon BR. Normal Iron Metabolism and Iron Toxicity. In: Handbook of Iron Overload Disorders. 1st ed. UK: Cambridge University Press; 2010:10–32.
   Google Scholar
• Argyropoulou MI, Kiortsis DN, Astrakas L, Metafratzi Z, Chalissos N, Efremidis SC. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 Relaxometry Study. Eur Radiol. 2007;17(12):3025–3030. doi:10.1007/s00330-007-0683-1
   PubMed Web of Science ®Google Scholar
• Chirico V, Rigoli L, Lacquniti A, et al. Endocrinopathies, metabolic disorders, and iron overload in thalassemia major and intermedia: serum ferritin as diagnostic and predictive markers associated with liver and cardiac T2 * MRI assessment. Eur J Haematol. 2014;1–9.
   Web of Science ®Google Scholar
• Soesanti F, Putriasih SA, Pulungan A, Wahidiyat PA. Endocrinopathies in thalassemia major patients in thalassemia center in Jakarta, Indonesia. Int J Pediatr Endocrinol. 2013;2013(S1):58. doi:10.1186/1687-9856-2013-S1-P58
   Google Scholar
• Soliman AT, Al Yafei F, Al-Naimi L, Almarri N, Sabt A, Yassin M, et al. Longitudinal study on thyroid function in patients with thalassemia major: high incidence of central hypothyroidism by 18 years. Indian J Endocrinol Metab. 2013;17(6):1090–5.
   Google Scholar
• Rashid HM, Shirodkar A, Ahmed J. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in thalassemia patients multitransfused Indian. Indian J Pediatr. 2011;78(6):679–683. doi:10.1007/s12098-010-0351-3
   Web of Science ®Google Scholar
• Eshragi P, Tamaddoni A, Zarifi K, Mohammadhasani A, Aminzadeh M. Thyroid function in patients with thalassemia major: is it related to height and chelation therapy ? Casp J Intern Med. 2011;2(1):190–193.
   Google Scholar
• Scacchi M, Danesi L, Cattaneo A, Valassi E, Giraldi FP, Argento C, et al. Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrin. 2007;67(5):790–5.
   Google Scholar
• Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C, et al. Assessment of thyroid function in two hundred patients with betathalassaemia major. Thyroid. 2002;12:151–4.
   Google Scholar
• Al-Hakeim HK, Al-Hakany MF. The effect of iron overload on the function of some endocrine glands in β-thalassemia major patients. Magazin of Al-kufa University for Biology. 2013;5:1–22.
   Google Scholar
• Moayeri H, Oolomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretions in beta-thalassemia major. Arch Iran Med. 2006;9(4):329–334.
   PubMedGoogle Scholar
• Hasibuan FD, Atmakusuma TD, Purnamasari D, Rumende CM. Korelasi antara muatan besi berlebih dengan fungsi endokrin pada pasien dewasa thalassemia beta bergantung transfusi yang mengalami retardasi pertumbuhan [The Correlation Between Iron Overload and Endocrine Function in Adult Transfusion Dependent Beta Thalassemia Patients with Growth Retardation] [Thesis]. Indonesia; 2018.
   Google Scholar